Investigating psychological patterns in individuals with suicidal thoughts and behaviors
Differences Between Suicide Attempters and Suicide Ideators. Influence of the Brief Therapy ASSIP on Neuropsychological Correlates and Psychological Process Factors (NePsyASSIP HT) - Project 1
This study is trying to understand the mental differences between people who have thought about or attempted suicide and those who haven't, to see if a new home treatment could help those at risk.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 180 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Bern Academic / other |
| Locations | 1 site (Bern) |
| Trial ID | NCT06248268 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore the neuropsychological differences between individuals who have attempted suicide, those with suicidal ideation, a clinical control group, and healthy controls. Participants will undergo a one-time neuropsychological assessment at the University Hospital of Psychiatry and Psychotherapy Bern in Switzerland. The study seeks to identify psychological factors that differentiate these groups and to assess the feasibility of a specific home treatment approach for those at risk. The findings could enhance understanding of the transition from suicidal thoughts to actions.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with a history of suicide attempts or current suicidal ideation.
Not a fit: Patients with serious cognitive impairments or psychotic disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved identification and treatment strategies for individuals at risk of suicide.
How similar studies have performed: While there have been studies on suicide risk factors, this specific approach focusing on neuropsychological patterns is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Subjects fulfilling the following inclusion criteria are eligible for the study: * Informed consent as documented by signature * Age ≥ 18 years Additional inclusion criterion for the SUAT group in project 1: • At least one previous suicide attempt Additional inclusion criterion for the SUID group in project 1: • Suicidal ideation Additional inclusion criterion for the CLIN group in project 1: • Current psychiatric disorder treated on an inpatient, day-care or outpatient basis For the HLTH group, no further inclusion criteria are formulated. Exclusion Criteria: The presence of any one of the following exclusion criteria leads to exclusion of the subject: * Serious cognitive impairment * Any current psychotic disorder * Any current medication, which substantially impairs the attention span, reaction rate or any other relevant cognitive functions * Inability to follow the procedures of the study (e.g., insufficient mastery of the German language, previous enrolment into the current study) Additional exclusion criterion for the SUID group: • Previous suicidal behavior Additional exclusion criteria for the CLIN and HLTH groups: * Previous suicidal behavior * Suicidal ideation Additional exclusion criterion for the HLTH group: • Current psychiatric disorder treated on an inpatient, day-care or outpatient basis
Where this trial is running
Bern
- University Hospital of Psychiatry and Psychotherapy, University of Bern — Bern, Switzerland (Recruiting)
Study contacts
- Principal investigator: Anja C. Gysin-Maillart, PD Dr. phil. — University of Bern, University Hospital of Psychiatry, Translational Research Center
- Study coordinator: Anja C. Gysin-Maillart, PD Dr. phil.
- Email: anja.gysin-maillart@unibe.ch
- Phone: +41 (0) 31 632 88 11
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.